-
121
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
122
Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developin...
Published 2022-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
123
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung
Published 2021-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
124
Acknowledging and addressing real-world challenges to treating immune-related adverse events
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
125
Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
126
Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
127
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
128
Urine proteomics defines an immune checkpoint-associated nephritis signature
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
129
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
130
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the Che...
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
131
Arginase-1-specific T cells target and modulate tumor-associated macrophages
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
132
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
133
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
134
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Published 2021-04-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
135
Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis
Published 2023-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
136
Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy
Published 2024-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
137
B7-H3 CAR-T cell therapy combined with irradiation is effective in targeting bulk and radiation-resistant chordoma cancer cells
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
138
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y glo...
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
139
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
Published 2022-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
140
Carbohydrate ligand engagement with CD11b enhances differentiation of tumor-associated myeloid cells for immunotherapy of solid cancers
Published 2023-06-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article